Creative Medical Technology Holdings (CELZ) Enterprise Value (2016 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Enterprise Value for 11 consecutive years, with -$6.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 123.16% year-over-year to -$6.8 million in Q2 2026; TTM through Jun 2026 was -$6.8 million, a 123.16% decrease from a year earlier, with the FY2025 full-year figure at -$4.5 million, down 62.82% from the prior year.
• Enterprise Value was -$6.8 million for Q2 2026 at Creative Medical Technology Holdings, down from -$3.0 million in the prior quarter.
• Over five years, Enterprise Value peaked at $16.3 million in Q1 2022 and troughed at -$16.1 million in Q2 2022.
• A 5-year average of -$4.4 million and a median of -$3.8 million in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value jumped 120.13% in 2023 and slumped 200.1% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at -$14.2 million in 2022, then jumped by 120.13% to $2.9 million in 2023, then tumbled by 200.1% to -$2.9 million in 2024, then sank by 60.07% to -$4.6 million in 2025, then sank by 47.26% to -$6.8 million in 2026.
• The last three Enterprise Value figures came in at -$6.8 million (Q2 2026), -$3.0 million (Q1 2026), and -$4.6 million (Q4 2025), per Business Quant data.